Moderate Evidence
Research Overview
Thymogen Research for Respiratory Infections
An evidence-based overview of research examining Thymogen in the context of respiratory infections. This page synthesizes findings from peer-reviewed literature.
Research Summary
Russian clinical literature reports Thymogen use for prevention and treatment of respiratory infections. The peptide is approved in Russia as an intranasal spray for these indications. Western clinical trials have not been conducted to validate these uses.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Respiratory Infections
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Thymogen may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.